ReviewWorld journal of microbiology & biotechnology2026
Advances in the biological production of butyric acid.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Butyric acid, a short-chain organic acid, is extensively used in the chemical, food, and pharmaceutical industries. Given the constraints in raw materials for traditional chemical synthesis and the rising consumer preference for natural products, microbial fermentation has emerged as a promising and sustainable alternative for butyric acid manufacture. This review provides a detailed elaboration of four biosynthetic pathways for microbial butyric acid production. It summarizes recent advances in butyric acid producers, encompassing both natural producers like Clostridium and emerging producers such as Escherichia coli. Their fermentation performance is systematically compared based on key metrics, including yield, tolerance, substrate utilization range, and process maturity. Butyric acid production was improved through targeted metabolic engineering and optimized fermentation processes, working in concert to enhance overall biosynthesis efficiency. Finally, it concludes with a summary and a perspective on future research priorities, which are anticipated to focus on systems metabolic engineering and integrated bioprocess development to enhance economic feasibility.
Indexed as
Identifiers
41554995What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.